These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Individualization of immunosuppressive therapy. II. Sirolimus as a less nephrotoxic alternative to calcineurin inhibitors. Lisik W; Kahan BD Transplant Proc; 2006; 38(1):69-73. PubMed ID: 16504667 [TBL] [Abstract][Full Text] [Related]
7. Trends in immunosuppression after pancreas transplantation: what is in the pipeline? Kimelman M; Brandacher G Curr Opin Organ Transplant; 2013 Feb; 18(1):76-82. PubMed ID: 23254700 [TBL] [Abstract][Full Text] [Related]
9. Methods and outcomes of calcineurin inhibitor reduction or withdrawal in patients with chronic allograft nephropathy after the first year posttransplantation. Weir MR Transplant Proc; 2001 Jun; 33(4 Suppl):19S-28S. PubMed ID: 11406264 [No Abstract] [Full Text] [Related]
10. [Evidences in immunosuppression in the maintenance of renal transplantation]. Hernández D; González-Posada JM Nefrologia; 2005; 25(4):369-80. PubMed ID: 16231502 [No Abstract] [Full Text] [Related]
11. Is complete avoidance of calcineurin inhibitors or steroids now possible? Importance of patient selection and choice of regimen. Vincenti F Transplant Proc; 2001 Jun; 33(4 Suppl):11S-18S. PubMed ID: 11406263 [No Abstract] [Full Text] [Related]
15. Fixed-dose sirolimus with reduced dose calcineurin inhibitor: the University of Colorado experience. Wiseman AC; Kam I; Christians U; Jani A; Bak T; Wachs M; Chan L Transplant Proc; 2003 May; 35(3 Suppl):122S-124S. PubMed ID: 12742482 [No Abstract] [Full Text] [Related]
16. Steroid withdrawal for pancreas transplants under tacrolimus immunosuppression. Jordan ML; Chakrabarti P; Luke PP; Shapiro R; Vivas CA; Scantlebury VP; Hakala TR; Fedorek S; Corry RJ Transplant Proc; 2001; 33(1-2):1655. PubMed ID: 11267456 [No Abstract] [Full Text] [Related]
17. Steroid-free maintenance immunosuppression with rapamune and low-dose neoral in pancreas transplant recipients. Rajab A; Pelletier RP; Ferguson RM; Elkhammas EA; Bumgardner GL; Henry ML Transplantation; 2007 Nov; 84(9):1131-7. PubMed ID: 17998868 [TBL] [Abstract][Full Text] [Related]
18. Excellent results with calcineurin inhibitor-free initial immunosuppression in old recipients of old kidneys. Bösmüller C; Ollinger R; Mark W; Brandacher G; Schneeberger S; Cakar F; Bonatti H; Margreiter R Transplant Proc; 2005 Mar; 37(2):881-3. PubMed ID: 15848563 [TBL] [Abstract][Full Text] [Related]
19. Sirolimus in kidney transplantation indications and practical guidelines: de novo sirolimus-based therapy without calcineurin inhibitors. Flechner SM Transplantation; 2009 Apr; 87(8 Suppl):S1-6. PubMed ID: 19384179 [TBL] [Abstract][Full Text] [Related]
20. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]